In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

The promising outlook for liquid biopsy diagnosis has sparked the interest of many in the biotech industry. The speed, ease, ...

Clinical trial design, like much of the industry, is experiencing a wave of innovation and disruption. Classical randomized control trials ...

The FDA has welcomed the use of AI in medical devices, as evidenced by the former commissioner’s optimistic attitude about ...

For industry veterans, the 2019 generics industry trends reflect many of the dynamics, challenges, and opportunities that have faced the ...

Underlying all of the widespread uses of genetic testing—diagnostic testing, carrier testing, prenatal testing, consumer-oriented genetic testing, etc.—few issues loom ...

The life sciences sector is inherently complex, operating under different pressures and influences compared to other industries. While the industry ...

The 2019 pharmaceutical trends build off an exciting 2018 in pharma with new developments in artificial intelligence, R&D, personalized medicine, ...

Although 2018 was another year of balanced growth globally, life sciences companies will be entering the new year facing challenges ...

As medical device makers look forward to 2019, opportunities abound for growth and innovation leveraging new technologies and strategies for ...

On November 26, 2018, FDA Commissioner Scott Gottlieb and Jeff Shuren, Director of the Center for Devices and Radiological Health, ...

Over the last two years, discussions about the applications of AI have broken through the mainstream and reached a level ...